GLIOBLASTOMA, WHO GRADE IV
Clinical trials for GLIOBLASTOMA, WHO GRADE IV explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, WHO GRADE IV trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, WHO GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain cancer: triple attack shows promise in early trial
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard treatment (chemotherapy plus a device that sends electric fields to the brain) can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 40 adults with good physical functi…
Matched conditions: GLIOBLASTOMA, WHO GRADE IV
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New drug-radiation combo targets deadly brain tumors in early trial
Disease control OngoingThis early-phase trial tests whether adding the drug quisinostat to standard radiation therapy can help control glioblastoma, a fast-growing brain cancer. About 30 adults with newly diagnosed or recurrent glioblastoma will receive the drug before and during radiation. The goal is…
Matched conditions: GLIOBLASTOMA, WHO GRADE IV
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 15, 2026 11:54 UTC